Seasonal Variations in Gut Microbiota and Disease Course in Patients with Inflammatory Bowel Disease

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2023 Apr 18

PMID 37071621

Authors

Mizuki Tani

Shinichiro Shinzaki

Akiko Asakura

Taku Tashiro

Takahiro Amano

Yuriko Otake-Kasamoto

Takeo Yoshihara

Shunsuke Yoshii

Yoshiki Tsujii

Yoshito Hayashi

Takahiro Inoue

Daisuke Motooka

Shota Nakamura

Hideki Iijima

Tetsuo Takehara

Affiliations

Soon will be listed here.

Abstract

Background And Aim: Environmental factors are associated with onset and course of inflammatory bowel disease (IBD). Our previous study by about 1,100 IBD patients revealed half of the patients experienced seasonal exacerbation of disease. We investigated the seasonality of fecal microbiota composition of IBD patients.

Methods: Fecal samples were consecutively collected in each season from IBD outpatients and healthy controls between November 2015 and April 2019. Participants who were treated with full elemental diet or antibiotics within 6 months or had ostomates were excluded. Bacterial profiles were analyzed by 16S rRNA sequencing, and the changes between the diseases and seasons were compared.

Results: A total of 188 fecal samples were analyzed from 47 participants comprising 19 Crohn's disease (CD) patients, 20 ulcerative colitis (UC) patients, and 8 healthy controls (HC). In CD patients, the phylum Actinobacteria and TM7 were both significantly more abundant in autumn than in spring and winter, but not in UC patients and HC. Moreover, the genera Actinomyces, a member of Actinobacteria, and c_TM7-3;o_;f_;g_ (TM7-3), that of TM7, were significantly more abundant in autumn than in spring, and the abundance of Actinomyces was significantly correlated with that of TM7-3 throughout the year in CD patients, but not in UC patients and HC. CD patients with high abundance of TM7-3 in the autumn required significantly fewer therapeutic intervention than those without seasonal fluctuation.

Conclusions: Oral commensals Actinomyces and its symbiont TM7-3 were correlatively fluctuated in the feces of CD patients by season, which could affect the disease course.

Citing Articles

Two-Year Study on the Intra-Individual Dynamics of Gut Microbiota and Short-Chain Fatty Acids Profiles in Healthy Adults.

Senina A, Markelova M, Khusnutdinova D, Siniagina M, Kupriyanova O, Synbulatova G Microorganisms. 2024; 12(8).

PMID: 39203554 PMC: 11357285. DOI: 10.3390/microorganisms12081712.

Climate Change and Psychiatry: The Correlation between the Mean Monthly Temperature and Admissions to an Acute Inpatient Unit.

Rizzo Pesci N, Teobaldi E, Maina G, Rosso G Int J Environ Res Public Health. 2024; 21(7).

PMID: 39063403 PMC: 11276805. DOI: 10.3390/ijerph21070826.

References

Docktor M, Paster B, Abramowicz S, Ingram J, Wang Y, Correll M . Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2011; 18(5):935-42. PMC: 4208308. DOI: 10.1002/ibd.21874. View

Vassa N, Mubarik A, Patel D, Muddassir S . Actinomyces turicensis: An unusual cause of cervicofacial actinomycosis presenting as ludwig angina in an immunocompromised host - Case report and literature review. IDCases. 2019; 18:e00636. PMC: 6806453. DOI: 10.1016/j.idcr.2019.e00636. View

Takeuchi T, Miyauchi E, Kanaya T, Kato T, Nakanishi Y, Watanabe T . Acetate differentially regulates IgA reactivity to commensal bacteria. Nature. 2021; 595(7868):560-564. DOI: 10.1038/s41586-021-03727-5. View

Kuehbacher T, Rehman A, Lepage P, Hellmig S, Folsch U, Schreiber S . Intestinal TM7 bacterial phylogenies in active inflammatory bowel disease. J Med Microbiol. 2008; 57(Pt 12):1569-1576. DOI: 10.1099/jmm.0.47719-0. View

Chipashvili O, Utter D, Bedree J, Ma Y, Schulte F, Mascarin G . Episymbiotic Saccharibacteria suppresses gingival inflammation and bone loss in mice through host bacterial modulation. Cell Host Microbe. 2021; 29(11):1649-1662.e7. PMC: 8595704. DOI: 10.1016/j.chom.2021.09.009. View

Tennert C, Reinmuth A, Bremer K, Al-Ahmad A, Karygianni L, Hellwig E . An oral health optimized diet reduces the load of potential cariogenic and periodontal bacterial species in the supragingival oral plaque: A randomized controlled pilot study. Microbiologyopen. 2020; 9(8):e1056. PMC: 7424251. DOI: 10.1002/mbo3.1056. View

Haberman Y, Tickle T, Dexheimer P, Kim M, Tang D, Karns R . Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest. 2014; 124(8):3617-33. PMC: 4109533. DOI: 10.1172/JCI75436. View

Nagalingam N, Lynch S . Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 2011; 18(5):968-84. DOI: 10.1002/ibd.21866. View

Nakase H, Uchino M, Shinzaki S, Matsuura M, Matsuoka K, Kobayashi T . Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol. 2021; 56(6):489-526. PMC: 8137635. DOI: 10.1007/s00535-021-01784-1. View

10.

Dubois G, Girard C, Lapointe F, Shapiro B . The Inuit gut microbiome is dynamic over time and shaped by traditional foods. Microbiome. 2017; 5(1):151. PMC: 5689144. DOI: 10.1186/s40168-017-0370-7. View

11.

Imhann F, Bonder M, Vich Vila A, Fu J, Mujagic Z, Vork L . Proton pump inhibitors affect the gut microbiome. Gut. 2015; 65(5):740-8. PMC: 4853569. DOI: 10.1136/gutjnl-2015-310376. View

12.

Acevedo F, Baudrand R, Letelier L, Gaete P . Actinomycosis: a great pretender. Case reports of unusual presentations and a review of the literature. Int J Infect Dis. 2008; 12(4):358-62. DOI: 10.1016/j.ijid.2007.10.006. View

13.

Lewis J, Chen E, Baldassano R, Otley A, Griffiths A, Lee D . Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease. Cell Host Microbe. 2015; 18(4):489-500. PMC: 4633303. DOI: 10.1016/j.chom.2015.09.008. View

14.

Park S, Hwang B, Lim M, Ok S, Lee S, Chun K . Oral-Gut Microbiome Axis in Gastrointestinal Disease and Cancer. Cancers (Basel). 2021; 13(9). PMC: 8125773. DOI: 10.3390/cancers13092124. View

15.

Best W, Becktel J, SINGLETON J, KERN Jr F . Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976; 70(3):439-44. View

16.

Brito F, Barros F, Zaltman C, Carvalho A, Carneiro A, Fischer R . Prevalence of periodontitis and DMFT index in patients with Crohn's disease and ulcerative colitis. J Clin Periodontol. 2008; 35(6):555-60. DOI: 10.1111/j.1600-051X.2008.01231.x. View

17.

Sartor R . Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006; 3(7):390-407. DOI: 10.1038/ncpgasthep0528. View

18.

Ananthakrishnan A . Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015; 12(4):205-17. DOI: 10.1038/nrgastro.2015.34. View

19.

Callahan B, McMurdie P, Rosen M, Han A, Johnson A, Holmes S . DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016; 13(7):581-3. PMC: 4927377. DOI: 10.1038/nmeth.3869. View

20.

Yamada T, Hino S, Iijima H, Genda T, Aoki R, Nagata R . Mucin O-glycans facilitate symbiosynthesis to maintain gut immune homeostasis. EBioMedicine. 2019; 48:513-525. PMC: 6838389. DOI: 10.1016/j.ebiom.2019.09.008. View